DVA

Ticker

DVA

Congressional Trades

by 3 members

Ticker Intelligence Brief

Who in Congress traded DVA, when, and what happened after?

A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.

Latest receipt

Julie Johnson

SELL · 2025-09-25

Largest range

$1K – $15K

Julie Johnson

Slowest filing

34d

Jerry Moran

Best vs SPY

9.2%

Julie Johnson

Buys

25%

Sells

63%

Total Volume

$64K

midpoint

Unique Traders

members

Party Breakdown

Democrats5 · 63%

Republicans3 · 38%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthMODERATE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←

Month

→ Republican

—

Dec '23

0▲1▼

1▲

May '25

—

0▲4▼

Sep '25

—

Democrats1▲4▼Net sellers

Republicans0▲1▼Net sellers

Net buyingNet selling⚡ Party split

🏛️ Federal Contracts

all →

2026-05-29$248K
Department of Veterans Affairs
ACUTE INPATIENT DIALYSIS SERVICES
2026-05-29$0
Department of Veterans Affairs
INPATIENT DIALYSIS SERVICES
2026-05-13$3.8M
Department of Veterans Affairs
NATIONAL (VA-WIDE) DIALYSIS SERVICES EO 14398
2026-05-13$0
Department of Veterans Affairs
NATIONAL (VA-WIDE) DIALYSIS SERVICES EO 14398
2026-01-29$25.1M
Department of Veterans Affairs
EXPRESS REPORT: FY 26 DECEMBER NDSC EXPRESS REPORT
2026-01-26$632K
Department of Veterans Affairs
INPATIENT DIALYSIS SERVICES AT VACCHCS ORDERING PERIOD 2

💼 Lobbying Filings

all →

2026-04-21$60K
DAVITA INC
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
2026-04-20$1.2M
DAVITA INC
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entitie
2026-04-20$70K
DAVITA INC.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
2026-04-20$60K
DAVITA INC.
Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the budget and appropriations process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act
2026-04-20$20K
DAVITA INC.
Building support among disability and minority organizations in support of H.R. 6860 and S.1173. companion.
2026-04-20$0
DAVITA INC.
2026-04-17$90K
DAVITA INC.
Medicare and Medicaid reimbursement policies for specific kidney treatments.
2026-04-17$60K
DAVITA INC.
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
2026-04-10$20K
DAVITA INC
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
2026-04-09$50K
DAVITA
Dialysis services, FY2027 mil.con./ Veterans Affairs Appropriations Act, S.275, S.3466

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days

No trades

Last 90 Days

No trades

All-Time

▼25

2 buys8 total6 sells

$16K buys · $48K sells

Cumulative Net Position (buy vol − sell vol)

-$32K

2018-128 trades plotted2025-09

Trade Activity Timeline

Congressional buys & sells by month · last 5 months w/ activity

18/12

21/12

23/12

25/05

25/09

BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade

2 buyers ·3 sellers

BuySellOtherDot size ∝ trade size · top 3 most-active traders shown

Seasonal Rhythm

Congress buy/sell pressure by month & year

Each cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.

Net buyingNet sellingNo trades · number = trade count

Peak buy month: May · Peak sell month: Sep

Congressional Conviction Timeline

net positioning · alpha track recordBEARISH

2 buys6 sellscumulative α -9.5%5mo tracked

Monthly Net Flow (Buys − Sells)

Alpha data populates as trades are priced — check back once return benchmarks are computed.

All Disclosed Trades

Date	Member	Action	Amount	Filing Delay	Receipt
2025-09-25	DJulie Johnson	SELL	$1K – $15K	13d	receipt →
2025-09-25	DJulie Johnson	SELL	$1K – $15K	12d	receipt →
2025-09-25	DJulie Johnson	SELL	$1K – $15K	12d	receipt →
2025-09-05	DRo Khanna	SELL	$1K – $15K	28d	receipt →
2025-05-28	DRo Khanna	BUY	$1K – $15K	13d	receipt →
2023-12-14	RJerry Moran	SELL	$1K – $15K	34d	receipt →
2021-12-21	RJerry Moran	PARTIAL_SELL	$1K – $15K	615d	receipt →
2018-12-06	RJerry Moran	BUY	$1K – $15K	1726d	receipt →